Overview
The life sciences industry is characterized, in large part, by unending innovation driven by the constant demand for new medical therapies. It is equally characterized by a robust but evolving regulatory framework in which the development of new technologies tends to outpace the laws needed to govern them.
In such a dynamic environment, dominated by compliance issues and enforcement concerns, the need for savvy legal advice is essential to an organization’s success.
At Epstein Becker Green, we have a tight-knit team of life sciences attorneys and advisors with strong backgrounds in science, industry, and government. Our clients are often on the leading edge of new technologies, and they trust us to guide them in areas where the regulatory picture remains unclear. We help them understand not just the law, but also its practical implications so they can adopt workable approaches to their legal, regulatory, and business issues.
Navigating the Regulatory Landscape
In an industry where stringent compliance obligations accompany every facet of a product’s development and commercialization, few companies can navigate the regulatory landscape without help. Our clients look to us to devise an overall regulatory strategy for their product, and we work with them to decide how that strategy will be implemented. How, and by whom, will the therapy be used? What research will be needed? What claims will need substantiating? What reimbursement schemes make the most sense? The answers to such questions—and countless similar ones—form the basis of each application for regulatory approval and provide our clients with roadmaps for addressing compliance issues going forward.
Our deep understanding of both the applicable regulatory bodies and their enforcement mechanisms is key to every aspect of our client service. We represent clients in front of all such bodies, both in routine matters and in investigative inquiries. Our lawyers advise them on the development of their manufacturing and distribution systems. We arrange contracts defining their relationships with customers, vendors, and payors. We review their pricing options, and we sign off on advertising and promotional communications. All of these efforts—and much more—are designed to ensure that all operations are fully optimized from both a business and a regulatory standpoint.
Serving Our Clients
Our team of life sciences attorneys and advisors serves organizations across the length and breadth of the life sciences industry, including:
- Academic centers
- Artificial intelligence companies
- Biotechnology companies
- Clinical laboratories
- Combination product manufacturers
- Digital health (IoT) companies
- Food and Dietary Supplements
- Genetics and Genomics
- Human cellular and tissue products (HCT/P) manufacturers
- In vitro diagnostic innovators
- Investors in the life sciences industry
- Medical device manufacturers
- Pharmaceutical and biologic manufacturers
- Precision medicine laboratories
- Research institutions and investigators
- Research services vendors (including contract research organizations (CROs) and site management organizations (SMOs))
- Suppliers and distributors
- Telehealth companies
- Trade associations and industry coalitions
We cover a broad scope of products and services that fall within these general categories: research and development, clinical research support, product commercialization, FDA regulatory strategy, compliance and training, litigation, and transactions and capitalization.
Read less
Focus Areas
Services
- Academic and Clinical Research
- ADA and Public Accommodations
- Affirmative Action/OFCCP Compliance
- Appellate
- Business Torts, Competition & Trade Secrets
- Class Actions
- Commercial and Contract Litigation
- Construction Law
- Corporate & Transactional
- Corporate and Securities Litigation
- Corporate Compliance Program Development, Implementation, and Effectiveness
- Corporate Financing
- Corporate Governance
- Corporate Reorganization
- Cross-Border Data Transfers
- Cross-Border Transactions
- Cybersecurity Risk Assessment
- Data Asset Management
- Data Breach and Incident Response
- Data Breach/Cybersecurity Investigations & Litigation
- Data Protection
- Dietary Supplement Litigation
- Digital Health
- Diversity, Equity & Inclusion Counseling
- Drug and Medical Device Coding, Coverage, and Payment
- Drug and Medical Device Distribution
- Drug and Medical Device Litigation
- Drug Pricing Policy & Reporting
- Employee Benefits and ERISA
- Employment Compliance Counseling
- Employment Litigation
- Employment Training
- Employment, Labor & Workforce Management
- ERISA – Retirement and Benefit Plan Litigation
- Executive Compensation
- FDA Inspections and Enforcement
- Federal Research Grants: Compliance, Investigations & Enforcement
- Financial Restructuring and Bankruptcy
- Foreign Multinational Counseling and Litigation
- General Counsel Services
- Health Care
- Health Care and Life Sciences Investigations and Enforcement
- Health Care and Life Sciences Investor Services
- Health Policy and Legislation
- Immigration
- Insider Threats
- Intellectual Property
- Intellectual Property Litigation
- Internet of Things (IoT)
- Labor and Employment Due Diligence
- Labor Management Relations
- Life Sciences
- Life Sciences Due Diligence
- Litigation & Business Disputes
- Mergers, Acquisitions & Divestitures
- Occupational Safety and Health (OSHA)
- Pandemic Workforce Issues
- Pay Equity
- Privacy Compliance Strategies
- Privacy, Cybersecurity & Data Asset Management
- Product Marketing and Compliance
- Ransomware
- Real Estate
- Regulatory Strategy, Product Development, and Product Approvals
- Remote and Hybrid Work
- Social Media and the Workplace
- State Privacy Law Compliance
- Tax and Tax-Exempt Counseling
- Trade Secrets & Employee Mobility
- Wage and Hour
- Whistleblowing and Compliance
- White Collar Defense and Internal Investigations
- Workforce Government Relations
- Workforce Restructuring and Other Cost-Saving Mechanisms
- Workplace Investigations
Industries
Experience
Our Team
Media
Events
Upcoming Events
Past Events
- November 29, 2023
Insights
Insights
- Media CoveragePaul DeCamp Quoted in “Judges Order Arrests in Rare Labor Agency ‘Punch’ Over Defiance”2 minute read
- Media Coverage
Featured in Los Angeles Sentinel: Attorney Kimberly Carter Joins Epstein Becker Green Law Firm
1 minute read - Media Coverage
Featured in Law360: Employment Attorney Kim Carter Joins Epstein Becker Green
2 minute read - BlogsUnpacking Averages: Analyzing FDA Device-Related Citizens Petitions by Topic10 minute read
- Blogs
What to Do If the Government Knocks on Your Company’s Door … or Breaks It Down – Speaking of Litigation Podcast
28 minute read - Media CoverageKim Carter Featured in “Wake Up Call: Laterals, Moves, In-House”1 minute read
- Firm AnnouncementsEpstein Becker Green Bolsters West Coast Presence with Employment Attorney Kimberly Carter3 minute read
- Media CoverageKim Carter Featured in “Epstein Becker Green Adds Employment Attorney as Member in LA”1 minute read
- Firm AnnouncementsEpstein Becker Green’s Digital Marketing Strategies Earn Several “Top Performer” Rankings in the 2023 Social Law ...3 minute read
- Firm AnnouncementsEpstein Becker Green Awards 2023 Annual Core Values Champions4 minute read
- PublicationsBraidwood v Becerra’s Vaccine Access Threat3 minute read
- Publications
In Genesis Case, South Carolina District Court Scraps HRSA Interpretation of “Patient” Under 340B Statute
9 minute read - Media Coverage
As Featured in Law360: Epstein Becker Promotions Inch Up with 12 Members Named
2 minute read - Firm AnnouncementsEpstein Becker Green Announces 2024 Promotions6 minute read
- PublicationsDealing with Controversial Commentary? Some Guidance and Guardrails for Employers19 minute read
- Media CoverageJames Boiani Quoted in “FDA Moving Quickly on LDT Rulemaking as 2024 Elections, 2027 User Fee Renewal Loom” ...2 minute read
- PublicationsTelemental Health Laws: 2023 Overview10 minute read
- Media CoverageEleanor Chung Quoted in “Senators Told That AI Is Already Harming Patients”Fall 20232 minute read
- BlogsUnpacking Averages: Sample Size for Clinical Trials Used to Obtain FDA Medical Device Clearance13 minute read
- PublicationsVaccines in the Courts: A COVID-19-Induced Litigation Influx2 minute read
- Media CoverageRachel Snyder Good Quoted in “'Devil's in the Details' of Biden's AI Health Plans, Experts Say”3 minute read
- Media CoverageEpstein Becker Green Featured in “Share of Women Among Partner Promos Continues Growing”3 minute read
- Firm Announcements
Epstein Becker Green Recognized Among 2024 “Best Law Firms” by U.S. News – Best Lawyers®
6 minute read - BlogsFDA LDT Webinar Serves as a Reminder to Industry to Submit Comments on the Proposed Rule3 minute read
- BlogsWhite House Executive Order on Artificial Intelligence: Implications for the Health Care and Life Sciences Industries ...6 minute read
- Media Coverage
Featured in The Legal Intelligencer: Epstein Becker Green Snags Employment Benefits Team to Launch Pittsburgh Office ...
2 minute read - Media CoverageKathryn English, Sandra Mihok, Heather Stone Fletcher, William Carter, Samuel Nolan Featured in “5-Person Benefits ...3 minute read
- Media CoverageEpstein Becker Green Expands Pittsburgh Footprint Following Addition of 5 Former Attorneys from Eckert Seamans1 minute read
- Firm AnnouncementsEpstein Becker Green Expands Employee Benefits Practice with Five-Attorney Group in Pittsburgh3 minute read
- PublicationsCMS Seeks Stakeholder Feedback About Medicare Transaction Facilitator Services for the Medicare Drug Price Negotiation ...4 minute read
- PublicationsCalifornia Makes Its Strict Noncompete Law Even Stricter5 minute read
- PublicationsPreventive Antibody Products Are Immunizations2 minute read
- Media CoverageRichard Hughes Quoted in “An R.S.V. Shot for Infants Is in Short Supply. Here’s What to Know”4 minute read
- Media CoverageDavid Shillcutt Quoted in “Calls for Detail Emerge as Theme in Parity Rule Comments”3 minute read
- PublicationsCalifornia Employers: Increased Paid Sick Leave Effective January 1, 20246 minute read
- Media CoverageRichard Hughes Quoted in “RSV Vaccines Aren’t Covered by Medicare for These Vulnerable Groups”2 minute read
- BlogsCongress May Have a Vision for Psychedelic Regulation in the US5 minute read
- PublicationsNew York Restricts Assignment of Employee Intellectual Property7 minute read
- PublicationsORI Releases Notice of Proposed Rulemaking to Update 2005 Public Health Service Policies on Research Misconduct ...7 minute read
- PublicationsCalifornia Employers: Amended Ban-the-Box Regulations Effective October 1, 202314 minute read
- BlogsFull Steam Ahead: FDA Releases Proposed LDT Rule in Advance of Looming Government Shutdown4 minute read
- Firm Announcements
Twenty-One Attorneys Named to the 2023 New York Super Lawyers and Rising Stars Lists
12 minute read - PublicationsA Topic-Based Analysis of FDA Responses to FOIA Requests1 minute read
- Media CoverageRichard Hughes Quoted in “Federal Watchdog: One Quarter of HIV-Positive Medicaid Enrollees Missed Care”3 minute read
- Firm AnnouncementsEpstein Becker Green Named “Best of the Best” in LinkedIn Performance by BTI Consulting Group6 minute read
- PublicationsState Regulation of Pharmacy Benefit Managers: Tenth Circuit Holds That ERISA and Medicare Part D Preempt Key Parts of ...25 minute read
- Media CoverageRichard Hughes Quoted in “Preventive Services Recommendation May Not Increase Injectable PrEP Access”3 minute read
- Firm Announcements
Epstein Becker Green Attorneys Recognized by 2024 Best Lawyers for Excellence in the Legal Profession
12 minute read - PublicationsFTC Warns Against Contract Provisions It Believes Could Impede Its Investigations2 minute read
- Firm Announcements
Epstein Becker Green Receives New York Law Journal’s 2023 Innovation Award
4 minute read